BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35772627)

  • 1. Antianhedonic effects of serial intravenous subanaesthetic ketamine in anxious versus nonanxious depression.
    Zheng W; Yang XH; Gu LM; Tan JQ; Zhou YL; Wang CY; Ning YP
    J Affect Disord; 2022 Sep; 313():72-76. PubMed ID: 35772627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
    J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated intravenous infusions of ketamine: Neurocognition in patients with anxious and nonanxious treatment-resistant depression.
    Liu W; Zhou Y; Zheng W; Wang C; Zhan Y; Lan X; Zhang B; Li H; Chen L; Ning Y
    J Affect Disord; 2019 Dec; 259():1-6. PubMed ID: 31430662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression.
    Zheng W; Yang XH; Gu LM; Tan JQ; Zhou YL; Wang CY; Ning YP
    Front Psychiatry; 2022; 13():981981. PubMed ID: 36186882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression.
    Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP
    CNS Spectr; 2021 Aug; 26(4):362-367. PubMed ID: 32419678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression.
    Salloum NC; Fava M; Freeman MP; Flynn M; Hoeppner B; Hock RS; Cusin C; Iosifescu DV; Trivedi MH; Sanacora G; Mathew SJ; Debattista C; Ionescu DF; Papakostas GI
    Depress Anxiety; 2019 Mar; 36(3):235-243. PubMed ID: 30597688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions.
    Zheng W; Gu LM; Yang XH; Zhou YL; Wang CY; Lan XF; Zhang B; Ning YP
    Int J Psychiatry Clin Pract; 2023 Jun; 27(2):145-150. PubMed ID: 36309806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder.
    Zheng W; Gu L; Zhou Y; Wang C; Lan X; Zhang B; Li Z; Ning Y
    Curr Neuropharmacol; 2023; 21(4):1013-1021. PubMed ID: 36173064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Zarate CA
    Bipolar Disord; 2015 Jun; 17(4):438-43. PubMed ID: 25400146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression.
    Zheng W; Gu LM; Sun CH; Zhou YL; Wang CY; Lan XF; Zhang B; Ning YP
    J Affect Disord; 2022 Mar; 300():109-113. PubMed ID: 34965393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression.
    Zheng W; Yang XH; Gu LM; Tan JQ; Zhou YL; Wang CY; Ning YP
    Front Psychiatry; 2022; 13():1033019. PubMed ID: 36620669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between depression subtypes and response to repeated-dose intravenous ketamine.
    Wang C; Zhou Y; Zheng W; Liu W; Zhan Y; Li H; Chen L; Zhang B; Walter M; Li M; Li MD; Ning Y
    Acta Psychiatr Scand; 2019 Nov; 140(5):446-457. PubMed ID: 31483855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression.
    Zheng W; Gu LM; Zhou YL; Wang CY; Lan XF; Zhang B; Shi HS; Wang DF; Ning YP
    Front Psychiatry; 2021; 12():780975. PubMed ID: 34925104
    [No Abstract]   [Full Text] [Related]  

  • 14. Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.
    Thase ME; Demyttenaere K; Earley WR; Gustafsson U; Udd M; Eriksson H
    Depress Anxiety; 2012 Jul; 29(7):574-86. PubMed ID: 22753280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of antidepressant and anti-suicidal effects of repeated ketamine infusions in elderly and younger adults with depression.
    Zheng W; Zhou YL; Wang CY; Lan XF; Ning YP
    J Affect Disord; 2023 Aug; 334():145-151. PubMed ID: 37160235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression.
    Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Lan XF; Zhang B; Ning YP
    J Affect Disord; 2020 Oct; 275():38-43. PubMed ID: 32658821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term quality of life after repeated ketamine infusions in anxious and nonanxious patients with depression.
    Liang Y; You Z; Chen X; Liu G; Li W; Wang C; Lan X; Luo Z; Mai S; Zhang F; Zeng Y; Chen Y; Chen Y; Ning Y; Zhou Y
    J Affect Disord; 2024 Mar; 349():394-399. PubMed ID: 38211748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence.
    McIntyre RS; Rodrigues NB; Lipsitz O; Nasri F; Gill H; Lui LM; Subramaniapillai M; Kratiuk K; Teopiz K; Ho R; Lee Y; Mansur RB; Rosenblat JD
    J Psychopharmacol; 2021 Feb; 35(2):128-136. PubMed ID: 33040665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
    Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH
    Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project.
    Wiethoff K; Bauer M; Baghai TC; Möller HJ; Fisher R; Hollinde D; Kiermeir J; Hauth I; Laux G; Cordes J; Brieger P; Kronmüller KT; Zeiler J; Adli M
    J Clin Psychiatry; 2010 Aug; 71(8):1047-54. PubMed ID: 20673545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.